Orgenesis Secures An Additional $5 Million Investment From Metalmark Capital To Accelerate Growth Of Point-Of-Care Service Subsidiary
Amount Raised
$5 Million
Round Type
Venture
GermantownBiotechnologyDescription
Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies (CGT) at the point of care, and Metalmark Capital Partners (“Metalmark”), a leading private equity firm with extensive expertise in the healthcare sector, today announced that Metalmark has agreed to make an additional growth investment of $5 million into Orgenesis’ US-based point-of-care (POCare) services subsidiary, Morgenesis LLC (“Morgenesis”). This investment follows the previously announced investment of $30 million in November 2022. In addition, Metalmark has committed to investing up to an additional $15 million, subject to the achievement of certain milestones.
Quick answer
Orgenesis Inc. raised $5 Million in a funding round, dated May 10, 2023. Orgenesis Inc. is based in Germantown, Maryland, United States.
- How much did Orgenesis Inc. raise?
- Orgenesis Inc. raised $5 Million in a funding round on May 10, 2023.
- What does Orgenesis Inc. do?
- Orgenesis Inc. is a global biotech company committed to unlocking the potential of cell and gene therapies (CGTs) and pioneering a decentralized approach to processing since 2020.
- Where is Orgenesis Inc. based and how big is it?
- Orgenesis Inc. is based in Germantown, Maryland, United States.
- Who are the decision-makers at Orgenesis Inc?
- Fundz holds 1 contact at Orgenesis Inc. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Orgenesis Inc. that raised within 45 days of this round, from Fundz verified event records.
- S4 Medical Corp. raised $5.8M on June 23, 2023.
- AvoMD raised $5M (Funding Round) on June 23, 2023.
- DiaMedica Therapeutics raised $38M on June 23, 2023.
- BioSynchronicity raised $25K (Pre-Seed) on June 23, 2023.
- Calidi Biotherapeutics raised an undisclosed amount (Series B) on June 23, 2023.
- Myra Vision raised $12M on June 23, 2023.
Who to call at Orgenesis Inc., and when
A new round usually means Orgenesis Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Orgenesis Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Orgenesis Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Orgenesis Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Orgenesis Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Orgenesis Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.